In a world where quality and trust matter more than ever, kratom fans are doing their homework—and rightfully so. With countless vendors offering products that range from questionable to quality, finding a reliable source can feel like a full-time job. That’s where names like Oasis Kratom start popping up in honest conversations, not just ads.…
This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, Biosimilar & Animal Health. Check out our full report below:
Recursion Presents Preliminary P-Ib/II (TUPELO) Trial Data of REC-4881 for Familial Adenomatous Polyposis (FAP) at DDW 2025
Read More: Recursion
Chengdu Origen and Vanotech Report the First Patient Dosing in P-I (VAN-2401)…
Automation remained a quintessential force throughout 2024 in shaping the biopharma industry. 2025 on the other hand is experiencing advanced applications of automated tools and enablers in different aspects of drugs life cycles. PharmaShots through this magazine navigates automated packaging by decrypting the complexities of automation.
The magazine unfolds the role of automation in biopharma…
Taking control of your health at home has never been easier with the advent of accessible and user-friendly health technology. Such devices enable individuals to observe, monitor and act on their ailments without constantly traveling to a clinic or suffering the financial expense of doing so.
Wearable Devices
Wearables such as fitness trackers and smartwatches…
Shots:
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency
Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and patients
Henlius Collaborates with Sandoz for the Commercialization of HLX13. Our team at PharmaShots…
Teaching in healthcare involves guiding future professionals in how they think through problems, interact with colleagues, and make informed decisions during clinical work. If you’re involved in clinical training, your ability to teach effectively can influence how future clinicians treat patients and how confidently they move through high-pressure environments.
Courses focused on teaching methodologies help…
HLTH Europe is the continent’s #1 healthcare innovation event. Following an enormously successful first event in 2024 and the exponential growth of HLTH in the US, this landmark event is where global expertise meets local insight to address Europe's unique healthcare challenges and opportunities.
Don’t miss out on this opportunity to connect with like-minded individuals…
Shots:
AATD-associated liver disease is a progressive genetic disorder with no approved therapy, and liver transplantation remains the only option for patients with end-stage disease.
Fazirsiran is an investigational RNAi therapy designed to treat AATD-associated liver disease by lowering the production of Z-AAT.
PharmaShots welcomes Dr. Chinwe Ukomadu, Head of the Gastrointestinal and Inflammation Therapeutic…
Barbara Albientz, Chief Commercialization Officer, Helvion Pharmaceuticals, joins PharmaShots’ Managing Editor Himanshu Sehgal for a riveting dialogue exchange. Barbara shares her experience from the recently held Reuters Events Pharma 2025, where she joined as an affirmative team member for the debate Reality Check: Is Omnichannel Actually Working?
Barbara believes AI will be crucial in segmenting…
Michael Bierl, VP, Partnerships and GM at Flatiron Health, joins PharmaShots’ Managing Editor Himanshu Sehgal for an illuminating dialogue exchange. Michael shares his experience from the recently held Reuters Events Pharma 2025, where he joined as a presenter for the case study titled Bridging gaps: Leverage data, tech and RWE for enhanced healthcare access and…

